The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Innoviva's shift to specialty therapeutics is backed by strong financials and a robust pipeline. Read why INVA stock presents ...

The article provides several healthier alternatives to heavy cream that can be used in various recipes without sacrificing flavor. These substitutes, including coconut milk, Greek yogurt ...

Innoviva is entitled to receive royalties from GSK on sales of RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®. Innoviva’s other innovative healthcare assets include infectious disease and ...

Nvidia dominates the market for the computer chips that power AI, but it isn’t a monopoly. Here’s a look at publicly-traded Nvidia competitors. Many, or all, of the products featured on this ...

Finally, the developers of Ungoogled Chromium Browser have stripped all binaries from the source code and replaced them with user-provided alternatives. Ungoogled Chromium Browser is free and can ...

Sales of Advair/Seretide and Anoro Ellipta fell 2% each. Revlar/Breo Ellipta sales declined 5%. The decline in vaccine sales was primarily due to lower sales of its RSV vaccine Arexvy. The figure ...

GRAND RAPIDS, Mich. — Different fires, same cause say Grand Rapids Fire Department officials, making for a busy Tuesday evening. The first call came in just before 6 p.m. on Veto St NW near ...

As China’s DeepSeek threatens to dismantle Silicon Valley’s AI monopoly, a European alliance has emerged with an alternative to tech’s global order. They call their project OpenEuroLLM.